| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb115946ef5b837c3c25d97fdbb687f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8260065a8502af101a63706bda226f88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d7c8bc1f3589a0a09fa9f9e1e8723fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4523
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
1997-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d93293b1abdbfdfd3e4fbb9047c8226
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1af0687c2d9c2160667ab07a36412324
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_812c2ec3022eee71d3cb9440a6a8cc02 |
| publicationDate |
1997-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9746552-A1 |
| titleOfInvention |
1-(1h-pyrrol-2-ylmethyl)-2-piperidone as cell migration inhibitor |
| abstract |
The present invention is concerned with the compound 1-(1H-pyrrol-2-ylmethyl)-2-piperidone for use as a medicine, in particular for use as an agent for reducing excessive directional cell migration (as in metastasis); and with pharmaceutical compositions comprising a pharmaceutically acceptable carrier and the title compound as an active ingredient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1576110-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7700615-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1576110-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03106437-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7390826-B2 |
| priorityDate |
1996-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |